The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Anti-Inflammatory Drugs in the 21st Century
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: The treatment of rheumatoid arthritis
Simon, L. S. (2004) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2004.04.005 · Cited by 19
RetractedMartin, R. (1986) · Medical Entomology and Zoology · Cited by 8,752
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Drugs Which Inhibit Prostaglandin Biosynthesis
Flower, R. J. (1974) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06634-7 · Cited by 1,323
Kaminska, B. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.08.017 · Cited by 1,285
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
Grzanna, R., Lindmark, L., & Frondoza, C. G. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.125 · Cited by 778
Goodwin, J. S., Bankhurst, A. D., & Messner, R. P. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.6.1719 · Cited by 635
Non-Steroidal Anti-Inflammatory Drugs: Current Status and Rational Therapeutic Use
Hart, F. D., & Huskisson, E. C. (1984) · Drugs · doi:10.2165/00003495-198427030-00004 · Cited by 507
The p38 MAP kinase pathway as a therapeutic target in inflammatory disease
SAKLATVALA, J. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.009 · Cited by 408
Smith, J. W., Steiner, A. L., & Parker, C. W. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106511 · Cited by 395
Molecular Targets of Dietary Polyphenols with Anti-inflammatory Properties
Yoon, J.-H., & Baek, S. J. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.5.585 · Cited by 381
Serhan, C. N., Arita, M., Hong, S., & Gotlinger, K. (2004) · Lipids · doi:10.1007/s11745-004-1339-7 · Cited by 349
Bengmark, S. (2006) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710603000145 · Cited by 345
Vayssière, B. M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H., & Resche-Rigon, M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9979 · Cited by 311
Post-ischemic inflammation: molecular mechanisms and therapeutic implications
Zheng, Z., & Yenari, M. A. (2004) · Neurological Research · doi:10.1179/016164104x2357 · Cited by 291
(1964) · The Lancet · doi:10.1016/s0140-6736(64)90999-7 · Cited by 254
Papa, S., Bubici, C., Zazzeroni, F., Pham, C. G., Kuntzen, C., Knabb, J. R., Dean, K., & Franzoso, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401865 · Cited by 235
Maulik, N., Sato, M., Price, B. D., & Das, D. K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00632-2 · Cited by 229
Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins
Serhan, C. N. (2005) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200503000-00003 · Cited by 227
Infections Associated With Tumor Necrosis Factor-α Antagonists
Crum, N. F., Lederman, E. R., & Wallace, M. R. (2005) · Medicine · doi:10.1097/01.md.0000180044.19285.9a · Cited by 225
Powles, T. J., Clark, S. A., Easty, D. M., Easty, G. C., & Neville, A. M. (1973) · British Journal of Cancer · doi:10.1038/bjc.1973.154 · Cited by 195
Cyclooxygenases in the skin: pharmacological and toxicological implications
Lee, J. L., Mukhtar, H., Bickers, D. R., Kopelovich, L., & Athar, M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00301-6 · Cited by 189
Keeble, J. E., & Moore, P. K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704876 · Cited by 187
Prostaglandin Production and Bone Resorption by Dental Cysts
Harris, M., Jenkins, M. V., Bennett, A. B., & WILLS, M. R. (1973) · Nature · doi:10.1038/245213a0 · Cited by 169
Role of nuclear factor‐κB in the immune system and bone
Jimi, E., & Ghosh, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00329.x · Cited by 163
Therapeutic Intervention and Targets for Sepsis
Rice, T. W., & Bernard, G. R. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104356 · Cited by 158
Targeted Therapies for Esophageal Cancer
Tew, W. P., Kelsen, D. P., & Ilson, D. H. (2005) · The Oncologist · doi:10.1634/theoncologist.10-8-590 · Cited by 154
GOLDSTEIN, D. M., & Gabriel, T. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054985939 · Cited by 150
Metal and Inflammatory Targets for Alzheimers Disease
Rogers, J. T., & Lahiri, D. K. (2004) · Current Drug Targets · doi:10.2174/1389450043345272 · Cited by 150
Miwatashi, S., Arikawa, Y., Kotani, E., Miyamoto, M., Naruo, K., Kimura, H., Tanaka, T., Asahi, S., & Ohkawa, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050165o · Cited by 148
The use of NSAIDs in rheumatic disorders 2005: a global perspective
Kean, W. F., & Buchanan, W. W. (2005) · Inflammopharmacology · doi:10.1163/156856005774415565 · Cited by 139
ANTI-METASTATIC EFFECT OF ASPIRIN
Gasic, G. J., Gasic, T. B., & Murphy, S. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92581-0 · Cited by 137
Yeh, C., Chen, T.-P., Wu, Y., Lin, Y., & Lin, P. J. (2005) · Journal of Surgical Research · doi:10.1016/j.jss.2004.11.009 · Cited by 135
Abadie, E., Ethgen, D. J., Avouac, B. P., Bouvenot, G., Branco, J., Bruyère, O., Calvo, G., Devogelaer, J.-P., Dreiser, R.-L., Herrero‐Beaumont, G., et al. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.01.006 · Cited by 131
Allgayer, H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.18.s2.1.x · Cited by 129
Peifer, C., Wagner, G. K., & Laufer, S. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606775270323 · Cited by 127
Gao, J., Liu, X., & Rigas, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506893102 · Cited by 127
Nuclear factor kappa B—molecular biomedicine: the next generation
Celec, P. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.12.015 · Cited by 126
Parkinson, J. F. (2006) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152806776383125 · Cited by 124
Paik, J. H., ju, J. H., Lee, J. Y., Boudreau, M. D., & Hwang, D. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002329200 · Cited by 120
The eicosanoid cascade: possible role in gliomas and meningiomas: Figure 1
Nathoo, N., Barnett, G. H., & Golubic, M. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.57.1.6 · Cited by 111
Rainsford, K. D. (2004) · CRC Press eBooks · doi:10.1201/9780203646960 · Cited by 110
Self-citationClària, J., & Romano, M. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774370753 · Cited by 108
Dannhardt, G., & Laufer, S. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374237 · Cited by 103
Non-COX-2 targets and cancer: Expanding the molecular target repertoire of chemoprevention
Kashfi, K., & Rigas, B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.004 · Cited by 102
Multifaceted roles of cyclooxygenase-2 in lung cancer
Riedl, K., Krysan, K., Pǒld, M., Dalwadi, H., Heuzé‐Vourc'h, N., Dohadwala, M., Liu, M., Cui, X., Figlin, R. A., Mao, J. T., et al. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.04.003 · Cited by 101
Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma
Wu, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.04.002 · Cited by 95
STAT1 as a New Molecular Target of Anti-Inflammatory Treatment
de Prati, A. C., Ciampa, A. R., Cavalieri, E., Zaffini, R., Darra, E., Menegazzi, M., Suzuki, H., & Mariotto, S. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054546645 · Cited by 94
The impact of new biologicals in the treatment of rheumatoid arthritis
Weaver, A. L. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh203 · Cited by 91
Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators
Wu, K. K. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.11.001 · Cited by 89
Pellegatta, F., Bertelli, A. A. E., Staels, B., Duhem, C., Fulgenzi, A., & Ferrero, M. E. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1220 · Cited by 82
Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins
Petasis, N. A., Akritopoulou‐Zanze, I., Fokin, V. V., Bernasconi, G., Keledjian, R., Yang, R., Uddin, J., Venkata, K. C. N., & Serhan, C. N. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.020 · Cited by 76
Nitric Oxide–Donating Aspirin Prevents Pancreatic Cancer in a Hamster Tumor Model
Ouyang, N., Williams, J. L., Tsioulias, G. J., Gao, J., Iatropoulos, M. J., Kopelovich, L., Kashfi, K., & Rigas, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3118 · Cited by 76
Yoon, J., Kim, S. J., Hwang, S., Chang, S., Kang, S., & Chun, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212520200 · Cited by 73
Small Molecule p38 Inhibitors: Novel Structural Features and Advances from 2002-2005
Hynes, J. J., & Leftheris, K. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054985920 · Cited by 70
Makman, M. H. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.9.2127 · Cited by 68
REGULATION OF GENE TRANSCRIPTION BY BOTANICALS: Novel Regulatory Mechanisms
Shay, N. F., & Banz, W. J. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092639 · Cited by 67
Coxibs and Alzheimer's disease: Should they stay or should they go?
Firuzi, O., & Praticò, D. (2006) · Annals of Neurology · doi:10.1002/ana.20774 · Cited by 60
Royle, J., Ross, J. A., Ansell, I. F., Bollina, P. R., Tulloch, D., & Habib, F. K. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000132367.02834.41 · Cited by 59
Novel Targets for Antiinflammatory and Antiarthritic Agents
Kulkarni, R., Achaiah, G., & Sastry, G. N. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698945 · Cited by 58
Regulation of Macrophage Eicosanoid Generation Is Dependent on Nuclear Factor kappa B
Lo, C.-J., Cryer, H. G., Fu, M., & Lo, F. R. (1998) · doi:10.1097/00005373-199807000-00004 · Cited by 56
Bryant, C. E., Farnfield, B. A., & Janicke, H. J. (2003) · American Journal of Veterinary Research · doi:10.2460/ajvr.2003.64.211 · Cited by 56
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer
Dai, Y., & Wang, W.-H. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i18.2884 · Cited by 50
Hundley, T. R., & Rigas, B. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091363 · Cited by 50
Eicosanoids: lipid mediators of inflammation in transplantation
Rocha, P. N., Plumb, T. J., & Coffman, T. M. (2003) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0132-4 · Cited by 49
Rainsford, K. D. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7410-1 · Cited by 46
Self-citationCurrent and Novel Treatment Options for Actinic Keratosis
Jorizzo, J. L. (2004) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-004-0804-2 · Cited by 37
2 Non-Steroidal Anti-Inflammatory Drugs
Adams, S. S., & Cobb, R. (1967) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70442-9 · Cited by 35
COX-2 Blockade in Cancer Prevention and Therapy
Harris, B. D. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-302-6 · Cited by 35
Bm, J., Cw, P., & Philpott, G. W. (1971) · PubMed · Cited by 33
Lifelong Aspirin Supplementation as a Means to Extending Life Span
Phillips, T., & Leeuwenburgh, C. (2004) · Rejuvenation Research · doi:10.1089/rej.2004.7.243 · Cited by 31
Direct and Irreversible Inhibition of Cyclooxygenase-1 by Nitroaspirin (NCX 4016)
Corazzi, T., Leone, M., Maucci, R., Corazzi, L., & Gresele, P. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089896 · Cited by 30
Pharmacology and Toxicology of Ibuprofen
Rainsford, K. D. (2015) · Wiley eBooks · doi:10.1002/9781118743614.ch5 · Cited by 27
Self-citationHuguenin, S., Vacherot, F., Kheuang, L., Fleury‐Feith, J., Jaurand, M., Bolla, M., Riffaud, J.-P., & Chopin, D. K. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.291.3.3 · Cited by 26
Update in Medical Therapy of Ulcerative Colitis
Katz, S. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000170735.43887.3a · Cited by 23
Introduction — The coxib controversies
Rainsford, K. D. (2005) · Inflammopharmacology · doi:10.1163/156856005774415628 · Cited by 22
Self-citationDHAWAN, V. M., Schwalb, D. J., Shumway, M. J., Warren, M. C., Wexler, R. S., Zemtseva, I. S., Zifcak, B. M., & Janero, D. R. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.011 · Cited by 22
Friedmann, Y., Shriki, A., Bennett, E. R., Golos, S., Diskin, R., Marbach, I., Bengal, E., & Engelberg, D. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022962 · Cited by 22
Cyclooxygenase-2 inhibition in colorectal cancer: Boom or bust?
Sanborn, R. E., & Blanke, C. D. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.035 · Cited by 21
Side Effects and Toxicology of the Salicylates
Rainsford, K. D. (2004) · CRC Press eBooks · doi:10.1201/9780203646960-12 · Cited by 21
Self-citationSaji, S., Hirose, M., & Toi, M. (2004) · Breast Cancer · doi:10.1007/bf02968291 · Cited by 20
The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production
Sabat, M. P., VanRens, J. C., Clark, M. P., Brugel, T. A., Maier, J., Bookland, R. G., Laufersweiler, M. J., Laughlin, S. K., Gołȩbiowski, A., De, B., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.05.050 · Cited by 15
Hall, V. C., & Wolf, R. E. (1997) · PubMed · Cited by 14
Physiologic Implications of Medullary Carcinoma of the Thyroid Gland
Kaplan, E. L., & Peskin, G. W. (1971) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)39336-7 · Cited by 14
The effects and metabolic fate of nitroflurbiprofen in healthy volunteers
Zacharowski, P. A., Zacharowski, K., Donnellan, C., Johnston, A. E., Vojnovic, I., Forte, P., DELSOLDATO, P., Benjamin, N., & OBYRNE, S. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.05.008 · Cited by 13
The discovery, development and novel actions of nimesulide
Rainsford, K. D. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7410-1_1 · Cited by 12
Self-citationThe Discovery of Drugs to Treat Arthritis: A Historical View
Otterness, I. G. (1995) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9846-6_1 · Cited by 7
Evidence‐based update of chemotherapy options for metastatic colorectal cancer
Damjanović, D., Thompson, P. I., & Findlay, M. P. N. (2004) · ANZ Journal of Surgery · doi:10.1111/j.1445-1433.2004.03148.x · Cited by 7
NO-NSAIDs and cancer: promising novel agents
Rigas, B., Kalofonos, H. P., Lebovics, E., & Vagenakis, A. G. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00049-5 · Cited by 7
Epidemiology of Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer
Thun, M. J., & Henley, S. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-302-6_3 · Cited by 6
Research works printed but not linked: 51
- Bennett A, Charlier EM, McDonald AM, Simpson JS, Stamford IF. Bonedestruction by breast tumours. Prostaglandins. 1976;11:461–463. · doi:10.1016/0090-6980(76)90079-4
- Bennett A. Prostaglandins as factors in diseases of the alimentary tract. Adv Prostaglandin Thromboxane Res. 1976;2:547–555.
- Bennett A, McDonals AM, Simpson JS, Stamford IF. Breast cancer,prostaglandins, and bone metastases. Lancet. 1975;31:1218–1220. · doi:10.1016/s0140-6736(75)92197-2
- Bennett A, Del Tacca M. Proceedings: Prostaglandins in human colonic carcinoma. Gut. 1975;16:409.
- Bennett A, Effects of kinins and prostaglandins on the gut. Proc RSoc Med. 1971;64:12–13.
- Bernstein S. Historic reflection on steroids: Lederle and personal aspects. Steroids. 1992;57:392–402. · doi:10.1016/0039-128x(92)90083-l
- Bolos J. Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors. Mini Rev Med Chem. 2005;5:857–868. · doi:10.2174/1389557054867048
- Bolla M, Zoli W. Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines Apoptosis. 2006;11:1321–30.
- Brooks PM, Buchanan WW, Rosenbloom D, Bellamy N. Clinical efficacy and responses in therapy with anti-inflammatory and anti-rheumaticdrugs. In: Anti-Inflammatory and Anti-Rheumatic Drugs, Vol III: Anti-Rheumatic Drugs, Experimental Agents, and Clinical Aspects of Drug Use, K D Rainsford, ed. Boca Raton (Fl): CRC Press, 1985, 167–203.
- Chiroli V, Benedini F, Ongini E, Del Soldato P. Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case ofnitroderivatives of aspirin. Eur J Med Chem. 2003;38:441–446. · DOI
- Corazzi T, Leone M, Roberti R, Del Soldato P, Gresele P. Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2. Biochem Biophys Res Commun. 2003;311:897–903. · doi:10.1016/j.bbrc.2003.10.079
- Dargent D. Utilization of tanderil during radium therapy of cancer of the female genital apparatus. Lyon Med. 1969;221:1261–1262.
- De Leval X, Delarge J, Somers F, de Tullio P, Henrotin Y, Pirotte B, Dognè J-M. Recent advances in inducible cyclooxygenase(COX-2) inhibition. Curr Med Chem. 2000;7:1041–1062. · doi:10.2174/0929867003374417
- Diller DJ, Lin TH, Metzger A. The discovery of novel chemotypes of p38 kinase inhibitors. Curr Top Med Chem. 2005;5:953–965. · doi:10.2174/1568026054985948
- Elhajj II, Haydar AA, Hujairi NM, Goldsmith DJ. The role of inflammation in acute coronary syndromes: review of the literature. J Med Liban. 2004;52:96–102.
- Evans D, Williamson WRN. Chemistry of clinically active anti-inflammatory compounds. In: Anti-Inflammatory Compounds. New York & Basel: Marcel Dekker, 1987, 193–302.
- Fabbri F, Brigliadori G, Ulivi P, Tesei A, Vannini I, Rosetti M, Bravaccini S, Amadori D, Bolla M, Zoli W. Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinomacells. Apoptosis. 2005;10:1095–1103. · doi:10.1007/s10495-005-0619-7
- Gao J, Kashfi K, Rigas B. In vitro metabolism of nitricoxide-donating aspirin: the effect of positional isomerism. JPharmacol Exp Ther. 2005;312:989–997. · doi:10.1124/jpet.104.076190
- Goodwin JS, Bankhurst AD, Murphy SA, Selinger DS, Messner RP, Williams RC Jr. Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin. J. CLin. Lab. Immunol. 1978;1:197–199.
- Goldstein DM, Alfredson T, Bertrand J, Browner MF, Clifford K, Dalrymple SA, Dunn J, Freire-Moar J, Harris S, Labadie SS, LaFargue J, Lapierre JM, Larrabee S, Li F, Papp E, McWeeney D, Ramesha C, Roberts R, Rotstein D, San Pablo B, Sjogren EB, So OY,Talamas FX, Tao W, Trejo A, Villasenor A, Welch M, Welch T, Weller P, Whiteley PE, Young K, Zipfel S. Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)-phenyl]methanone(RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase. J Med Chem. 2006;49: 1562–1575. · doi:10.1021/jm050736c
- Harris RE. Epidemiology of breast cancer and nonsteroidal anti-inflammatory drugs. In: COX-2 Blockade in Cancer Prevention and Therapy. R.E. Harris, ed. Totawa, NJ: HumanaPress, 2002b, 57–68. · doi:10.1385/1-59259-302-x:57
- Hirschmann R. The cortisone era: aspects of its impact. Some contributions of the Merck Laboratories. Steroids.y1992;57:579–592. · doi:10.1016/0039-128x(92)90012-x
- Huguenin S, Fleury-Feith J, Kheuang L, Jaurand MC, Bolla M, Riffaud JP, Chopin DK, Vacherot F. Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug(NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines. Prostate. 2004a;61:132–141. · doi:10.1002/pros.20081
- JForl J. Trial of Tandearil in prevention of cutaneous and mucosal complications in patients with otoshinolaryngeal neoplasms treatedby irradiation. Otorhinolaryngeal Audiophonol Chir Maxillofac.1976;25:175–178.
- Klein U, Muller-Fassbender H, Bublath H, Heinze HG. Effects of oxyphenbutazone on radiation fibrosis following irradiation for breast carcinoma. Strahlentherapie. 1972;144:421–429.
- Levine L, Hinkle PM, Voelkel EF, Tashjian AH Jr. Prostaglandin production by moouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. Biochem Biophys Res Commun. 1972;47: 888–896. · DOI
- Lin TH, Metzger A, Diller DJ, Desai M, Henderson I, Ahmed G, Kimble EF, Quadros E, Webb ML. Discovery and characterization of triaminotriazine aniline amides as highly selective p38 kinase inhibitors. J Pharmacol Exp Ther. 2006;318:495–502. · DOI
- Lindahl F. Intestinal injuries following irradiation for carcinoma of the uterine cervix and vesical carcinoma. Acta Chir Scand. 1970;136:725–730.
- LiVolsi VA. Anti-metastatic effect of aspirin. Lancet. 1973;2:263. · doi:10.1016/s0140-6736(73)93169-3
- Metzger A, Diller DJ, Lin TH, Henderson I, Webb ML. Successful screening of large encoded combinatorial libraries leading to the discovery of novel p38 MAP kinase inhibitors. Comb Chem High Throughput Screen. 2006;9:351–358. · doi:10.2174/138620706777452384
- Muller-Fassbender H, Klein U, Bablath H, Heinze HG. Effect of oxyphenbutazone on radiation-induced lung diseases. Med Klin. 1973; 68:478–483.
- Nash P, Clegg DO. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii74–7. · doi:10.1136/ard.2004.030783
- O’Brien JR. Effects of salicylates on human platelets. Lancet. 1968; 1(4546), 779–783. · doi:10.1016/s0140-6736(68)92228-9
- Paulus HE. Clinical trial design for evaluating combination therapies. Br J Rheumatol. 1995;34 Suppl 2:92–95 · doi:10.1093/rheumatology/xxxiv.suppl_2.92
- Powles TJ, Easty DM, Easty GC, Neville AM. Tumor-induced osteolysis. N Engl J Med. 1974;291:105. · doi:10.1056/nejm197407112910221
- Powles TJ, Easty GC, Easty DM, Neville AM. Anti-metastatic effect of aspirin. Lancet. 1973;2:100. · doi:10.1016/s0140-6736(73)93300-x
- Prescott LF. Paracetamol (Acetaminiphen). A Critical Bibliographic Review. Revised 2nd Edn. London: Taylor & Francis, 2001.
- Rainsford KD. History and development of ibuprofen. In: Ibuprofen. A Critical Bibliographic Review, K.D. Rainsford, ed. London: Taylor & Francis, 1999a, 1–24. · doi:10.4324/9780203362587
- Rainsford KD. Pharmacology and Biochemistry of salicylates and related drugs. In: Aspirin and Related Drugs, K.D.Rainsford, ed. London and New York: Taylor & Francis, 2004c,215–366. · DOI
- Rainsford KD. Aspirin and NSAIDs in the prevention of cancer, Alzheimer’s disease and othe novel therapeutic actions. In: Aspirin and Related Drugs, K.D. Rainsford, ed. London and NewYork: Taylor & Francis, 2004d, 707–756. · DOI
- Rainsford KD. Inhibitors of eicosanoids. In: The Eicosanoids, P Curtis-Prior, ed. Chichester: John Wiley &Sons, 2004e, 189–210. · doi:10.1002/0470020628.ch16
- Rainsford KD. Occurrence, properties and synthetic developments ofthe salicylates. In: Aspirin and Related Drugs, K.D.Rainsford, ed. London & New York: Taylor & Francis, 2004f,45–95. · DOI
- Rainsford KD. Aspirin and NSAIDs in the prevention of cancer, Alzheimer’s disease and other novel therapeutic actions. In: Aspirin and Related Drugs, K.D. Rainsford, ed. London & NewYork: Taylor & Francis, 2004g, 707–756. · DOI
- Russo-Marie F. Antiinflammatory steroids. In: The Eicosanoids. P. Curtis-Prior, ed. Chichester: John Wiley &Sons, 2004, 327–332. · doi:10.1002/0470020628.ch28
- Sandler M, Karim SM, Williams ED. Prostaglandins in amine-peptide-secreting tumours. Lancet. 1968;2:1053–1054. · doi:10.1016/s0140-6736(68)91528-6
- Skinner R. Role of topical therapies in the management of cutaneous disease. J Cutan Med Surg. 2004;8 Suppl 3:22–31. · doi:10.1007/s10227-004-0805-1
- Trummlitz G, van Ryn J. Designing selective COX-2 inhibitors: molecular modeling approaches. Curr Opin Drug Discov Devel. 2002;5:550–561.
- Van Wijk R, Wicks WD, Clay, K. Effects of derivatives of cyclic 3′,5′ -adenosine monophosphate on the growth, morphology, and gene expression of hepatoma cells in culture. Cancer Res. 1972;32: 1905–1911.
- Webert KE, Kelton JG. Acetylsalicylic acid for prevention and treatment of thromboembolic diseases. In: Aspirin and Related Drugs, K.D. Rainsford, ed. London & New York: Taylor &Francis, 619–633.
- Whittle BJ. Nitric oxide and the gut injury induced by non-steroidal anti-inflammatory drugs. Inflammopharmacology. 2003;11:415–422. · doi:10.1163/156856003322699582
- Wood S Jr, Hilgard P. Aspirin and tumour metastasis. Lancet. 1972;2:1416–1417.
Cited by
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2012 · Cited by 2,484
“NSAIDs actions include nonselective inhibition of COX, thereby blocking formation of PGE2 (241).”
BackgroundPrediction of drug–target interaction networks from the integration of chemical and genomic spaces
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,147
A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018) · Aging and disease · doi:10.14336/ad.2017.0306 · Cited by 917
Chronic inflammation induces telomere dysfunction and accelerates ageing in mice
Jurk, D., Wilson, C., Passos, J. F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5172 · Cited by 819
Ibuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 667
Self-citation
Metadata
- Authors
- Rainsford, K. D.
- Venue
- Subcellular Biochemistry
- Publisher
- Springer Netherlands
- Published
- 2007
- Volume
- 42
- Pages
- 3-27
- ISSN
- 0306-0225 (ISSN-L)
- OpenAlex
- W129031804
- Cited by
- 463
- References
- 95
- FWCI
- 76.93
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.